News
Nadav Ahituv, PhD
Tue Feb 4, 2025
Department of Bioengineering and Therapeutic Sciences professor Nadav Ahituv is part of a team of researchers using the gene editing technology CRISPR to deprive tumors of nutrition.
Wed Feb 27, 2019
A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients.
Tue Feb 12, 2019
The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.
Thu Jan 17, 2019
A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.
Wed Jan 9, 2019
Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.
Wed Dec 19, 2018
Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.
Tue Nov 20, 2018
Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.
Thu Nov 15, 2018
Drug discovery today begins with computation rather than test tube experimentation. Three School of Pharmacy faculty emeriti, Robert Langridge, Irwin “Tack” Kuntz, and the late Peter Kollman, were awarded the UCSF Medal for creating computational tools for drug discovery that are now used worldwide.
Fri Nov 9, 2018
Curriculum transformation, An expanded role, Gaining recognition, Graduate match rate; School of Pharmacy scientists receive UCSF Medal: Founding fathers of drug discovery honored; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients;...
Fri Oct 26, 2018
Prof. Sourav Bandyopadhyay has been assiduous both in the laboratory and at his desk.
A couple of his recent papers have garnered much attention. One, “A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance,” identifies hundreds of potential new functional links between tumor...